UK Company Verso Biosense Develops “Smart IUD” to Monitor the Uterus in Real Time
Posted:
Verso Biosense, based in Oxfordshire, is developing a sensor-equipped intrauterine device designed to measure key physiological conditions inside the uterus – including temperature and oxygen levels – continuously over several days. The company says the technology could help unlock one of the least understood organs in the human body by providing data that has historically been impossible to collect.
The Bacillus Calmette-Guérin (BCG) vaccine prevents severe forms of tuberculosis (TB) and is the world’s most widely used vaccine, as well as the oldest vaccine still in use.
Read more here.
Cigna's Evernorth is investing $100 million through 2028 in specialty pharmacy care.
The AI program called Pharmacy Forward is expected to generate approximately $400 million in value by the end of 2028, according to Evernorth.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us